175 related articles for article (PubMed ID: 35545806)
1. Fatty acid synthase: a druggable driver of breast cancer brain metastasis.
Menendez JA; Lupu R
Expert Opin Ther Targets; 2022 May; 26(5):427-444. PubMed ID: 35545806
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid synthase (FASN) as a therapeutic target in breast cancer.
Menendez JA; Lupu R
Expert Opin Ther Targets; 2017 Nov; 21(11):1001-1016. PubMed ID: 28922023
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells.
Vazquez-Martin A; Colomer R; Brunet J; Lupu R; Menendez JA
Cell Prolif; 2008 Feb; 41(1):59-85. PubMed ID: 18211286
[TBL] [Abstract][Full Text] [Related]
4. FATTY ACID SYNTHESIS IS REQUIRED FOR BREAST CANCER BRAIN METASTASIS.
Ferraro GB; Ali A; Luengo A; Kodack DP; Deik A; Abbott KL; Bezwada D; Blanc L; Prideaux B; Jin X; Posada JM; Chen J; Chin CR; Amoozgar Z; Ferreira R; Chen IX; Naxerova K; Ng C; Westermark AM; Duquette M; Roberge S; Lindeman NI; Lyssiotis CA; Nielsen J; Housman DE; Duda DG; Brachtel E; Golub TR; Cantley LC; Asara JM; Davidson SM; Fukumura D; Dartois VA; Clish CB; Jain RK; Vander Heiden MG
Nat Cancer; 2021 Apr; 2(4):414-428. PubMed ID: 34179825
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in targeting the fatty acid biosynthetic pathway using fatty acid synthase inhibitors.
Angeles TS; Hudkins RL
Expert Opin Drug Discov; 2016 Dec; 11(12):1187-1199. PubMed ID: 27701891
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between osteoprotegerin (OPG), fatty acid synthase (FASN) and, cycloxygenase-2 (COX-2) in breast cancer: implications in carcinogenesis.
Goswami S; Sharma-Walia N
Oncotarget; 2016 Sep; 7(37):58953-58974. PubMed ID: 27270654
[TBL] [Abstract][Full Text] [Related]
7. Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: molecular mechanisms and therapeutic perspectives.
Menendez JA
Biochim Biophys Acta; 2010 Mar; 1801(3):381-91. PubMed ID: 19782152
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells.
Jin Q; Yuan LX; Boulbes D; Baek JM; Wang YN; Gomez-Cabello D; Hawke DH; Yeung SC; Lee MH; Hortobagyi GN; Hung MC; Esteva FJ
Breast Cancer Res; 2010; 12(6):R96. PubMed ID: 21080941
[TBL] [Abstract][Full Text] [Related]
9. Targeting fatty acid synthase in breast and endometrial cancer: An alternative to selective estrogen receptor modulators?
Lupu R; Menendez JA
Endocrinology; 2006 Sep; 147(9):4056-66. PubMed ID: 16809439
[TBL] [Abstract][Full Text] [Related]
10. Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer.
Corominas-Faja B; Vellon L; Cuyàs E; Buxó M; Martin-Castillo B; Serra D; García J; Lupu R; Menendez JA
Histol Histopathol; 2017 Jul; 32(7):687-698. PubMed ID: 27714708
[TBL] [Abstract][Full Text] [Related]
11. Suppression of endogenous lipogenesis induces reversion of the malignant phenotype and normalized differentiation in breast cancer.
Gonzalez-Guerrico AM; Espinoza I; Schroeder B; Park CH; Kvp CM; Khurana A; Corominas-Faja B; Cuyàs E; Alarcón T; Kleer C; Menendez JA; Lupu R
Oncotarget; 2016 Nov; 7(44):71151-71168. PubMed ID: 27223424
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological inhibitors of Fatty Acid Synthase (FASN)--catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents?
Lupu R; Menendez JA
Curr Pharm Biotechnol; 2006 Dec; 7(6):483-93. PubMed ID: 17168665
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr Virus-Encoded Latent Membrane Protein 1 and B-Cell Growth Transformation Induce Lipogenesis through Fatty Acid Synthase.
Hulse M; Johnson SM; Boyle S; Caruso LB; Tempera I
J Virol; 2021 Jan; 95(4):. PubMed ID: 33208446
[TBL] [Abstract][Full Text] [Related]
14. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis.
Menendez JA; Lupu R
Nat Rev Cancer; 2007 Oct; 7(10):763-77. PubMed ID: 17882277
[TBL] [Abstract][Full Text] [Related]
15. Destabilization of Fatty Acid Synthase by Acetylation Inhibits De Novo Lipogenesis and Tumor Cell Growth.
Lin HP; Cheng ZL; He RY; Song L; Tian MX; Zhou LS; Groh BS; Liu WR; Ji MB; Ding C; Shi YH; Guan KL; Ye D; Xiong Y
Cancer Res; 2016 Dec; 76(23):6924-6936. PubMed ID: 27758890
[TBL] [Abstract][Full Text] [Related]
16. FASN-dependent de novo lipogenesis is required for brain development.
Gonzalez-Bohorquez D; Gallego López IM; Jaeger BN; Pfammatter S; Bowers M; Semenkovich CF; Jessberger S
Proc Natl Acad Sci U S A; 2022 Jan; 119(2):. PubMed ID: 34996870
[TBL] [Abstract][Full Text] [Related]
17. Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer.
Tomek K; Wagner R; Varga F; Singer CF; Karlic H; Grunt TW
Mol Cancer Res; 2011 Dec; 9(12):1767-79. PubMed ID: 21970855
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid synthase (FASN) signalome: A molecular guide for precision oncology.
Menendez JA; Cuyàs E; Encinar JA; Vander Steen T; Verdura S; Llop-Hernández À; López J; Serrano-Hervás E; Osuna S; Martin-Castillo B; Lupu R
Mol Oncol; 2024 Mar; 18(3):479-516. PubMed ID: 38158755
[TBL] [Abstract][Full Text] [Related]
19. Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans.
Li L; Che L; Tharp KM; Park HM; Pilo MG; Cao D; Cigliano A; Latte G; Xu Z; Ribback S; Dombrowski F; Evert M; Gores GJ; Stahl A; Calvisi DF; Chen X
Hepatology; 2016 Jun; 63(6):1900-13. PubMed ID: 26910791
[TBL] [Abstract][Full Text] [Related]
20. Ovarian Cancer-Intrinsic Fatty Acid Synthase Prevents Anti-tumor Immunity by Disrupting Tumor-Infiltrating Dendritic Cells.
Jiang L; Fang X; Wang H; Li D; Wang X
Front Immunol; 2018; 9():2927. PubMed ID: 30619288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
